19 December 2018 1 Min Read
Drug maker GSK to split after folding in Pfizer consumer unit
The new joint venture with Pfizer is expected to generate total annual cost savings of £500m by 2022
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In